Vasudha Pharma Chem Limited
bd_58c43a97d80b2cdc · schema v1 · pii pii-v1
Full breach record for Vasudha Pharma Chem Limited →Threat-actor claim — not a regulatory filing
This row is a claim by the ransomware group LockBit 3.x on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Sanctions caution: LockBit 3.x carries US sanctions exposure — OFAC has designated the group or its operators. Public reporting is permitted (informational-materials exemption, 50 U.S.C. § 1702(b)(3)) — but any payment or material support may violate sanctions. Consult counsel before engaging.
Source: Ransomware.live
Post text · scraped from the leak site
VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telengana, India. The company is engaged in the manufacturing of APIs, Pharma Intermediates for catering t...
Source provenance
- Source URL
- https://www.ransomware.live/id/dmFzdWRoYXBoYXJtYS5jb21AbG9ja2JpdDM=
DisclosureLens links to the originating regulator URL — full filing bodies are not redistributed from public surfaces (§4.5).
- Filed at
- Jan 15, 2024
- Raw hash
- dcf76d17a1e53864ade62c485ea6121c16b2364d7e534179614ce255e7b43071
Reporting entity
- Name
- lockbit3norm: lockbit_3
Victim entity
- Name
- Vasudha Pharma Chem Limitednorm: vasudha pharma chem
- Domain
- vasudhapharma.com
- Industry
- Healthcare
What this source establishes
- Source ceiling
- A leak-site claim can't tell us: discovery date · materiality · notification · affected count · confirmed data types · compliance clock. These stay blank until a regulatory filing or victim disclosure lands.
- Attack vector
- Ransomware· lockbit_3
- Threat actor
- LockBit 3.xExternalFinancial
Compliance
- Compliance flags
- — (clock not assessable for this source)
Extraction provenance
- Status
- No extraction artifact recorded for this disclosure.